Status:
COMPLETED
Screening Type 2 Diabetes Mellitus on the 2nd Day After Delivery in Women With Gestational Diabetes Mellitus
Lead Sponsor:
Université de Sherbrooke
Collaborating Sponsors:
University of Toronto
University of Manitoba
Conditions:
Diabetes, Gestational
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Gestational diabetes mellitus (GDM) is defined as a hyperglycemia with onset or first recognition during pregnancy. GDM complicates 5 to 25% of pregnancies, depending on the diagnostic criteria used a...
Eligibility Criteria
Inclusion
- Women aged between 18 and 45 years;
- Having a positive diagnosis of gestational diabetes mellitus (GDM) (IADPSG or CDA criteria or patient followed for GDM);
- Treated with diet, insulin or oral hypoglycemic agents;
- Have given birth to a child at term (gestational age ≥ 37 weeks);
- Have signed the consent form.
Exclusion
- History of glucose intolerance or diabetes before the pregnancy;
- Have presented another obstetrical pathology during the pregnancy;
- Severe gestational high blood pressure with proteinuria;
- Delayed intrauterine development syndrome;
- Pregnancy with more than a foetus;
- Drug addiction;
- Had complications during the delivery such as:
- Moderate to severe postpartum bleeding;
- Surgery in postpartum (curettage, hysterectomy, etc.).
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT02290860
Start Date
December 1 2014
End Date
December 31 2018
Last Update
May 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de recherche clinique du CHUS
Sherbrooke, Quebec, Canada, J1H 5N4